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ulcerDear Editor,
Epstein-Barr virus-positive mucocutaneous ulcer (EBV-MUC)
is a rare provisional entity in the 2016 Update of World
Health Organization classification of lymphoid neoplasms
[1]. It is a localized EBV-associated lymphoproliferative
disorder characterized by a circumscribed ulcer involving
oropharyngeal mucosa, skin, or gastrointestinal tract in
immunocompromised patients [2]. Histologically, EBV-MUC
is characterized by a polymorphous infiltrate and atypical
large B cells with Hodgkin/ReedeSternberg (HRS) cell-like
morphology and admixed abundant T cells. The large B
cells are positive for EBV by in situ hybridization [2]. About
one-third of cases are clonal for immunoglobulin receptor
gene or T-cell receptor gene rearrangement [2]. These
pathological, immunophenotypical, and molecular features
might overlap with lymphoma. However, most EBV-MUC
cases show indolent course needing only conservative
treatment. Herein, we report the first Taiwanese case of
EBV-MUC who had a history of rheumatoid arthritis treated
with methotrexate.
A 58-year-old woman presented with a gingival ulcer for
3 weeks. She had rheumatoid arthritis and had been
treated with methotrexate for years. The ulcer, 1.0 cm 
0.5 cm in size, was deep and well-demarcated (Figure 1A).
Incisional biopsy showed a central ulceration with a poly-
morphous lymphoid infiltrate comprising small and medium
to large lymphocytes with irregular nuclear contours, some
resembling HRS cells (Figures 1B and 1C). Immunohis-
tochemically, most large atypical lymphocytes expressed
CD19, CD30, CD79a, PAX5, MUM-1, and LMP-1 and a reduced
expression of CD20, BOB-1, and Oct-2 in a background of
small CD3-positive T lymphocytes (Figures 1De1G). In situ
hybridization for EBV was positive in variable-sizedConflicts of interest: All authors declare no conflicts of interest.
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the ulcer (Figures 1H and 1I). Clonality study showed clonal
rearrangement of the immunoglobulin gene but polyclonal
for the T-cell receptor gene. After the diagnosis of EBV-
MUC, the ulcer improved spontaneously without recur-
rence 9 months after the biopsy.
In 2010, Dojcinov et al. [2] first described EBV-MUC in a
series of 16 elderly patients and additional nine patients
with iatrogenic immunosuppression. Immunosuppression
reduces T-cell-mediated immunosurveillance and leads to
proliferation of latently EBV-infected B cells. In 2014, Hart
et al. [3] reported seven patients of EBV-MUC in 70 solid
organ transplant recipients with EBV-positive post-trans-
plant lymphoproliferative disorder (PTLD). They found that
EBV-MUC patients lacked EBV DNA in blood, in contrast to
frequently elevated EBV DNA levels in the more aggressive
systemic PTLD. They concluded that EBV-MUC was a local-
ized type of PTLD and lack of EBV DNA in blood might be a
useful feature for distinguishing it from the more aggressive
forms of PTLD. In 2015, Bunn et al. [4] described two cases
of AIDS-related EBV-MUC. Most EBV-MUC cases are self-
limited, while only a few cases progressed or even trans-
formed into classical Hodgkin lymphoma (CHL) [5]. In the
latter cases, it is unclear whether EBV-MUC might be a
precursor of CHL or the initial diagnosis was actually EBV-
positive CHL with overlapping features with EBV-MUC. In
conclusion, EBV-MUC must be distinguished from the more
aggressive systemic PTLD and lymphomas, especially CHL,
EBV-positive diffuse large B-cell lymphoma, plasmablastic
lymphoma, and anaplastic large cell lymphoma. Thorough
clinicopathological investigation and awareness of this rare
entity are important for avoiding erroneous diagnosis and
overtreatment.rus-positive mucocutaneous ulcer, Kaohsiung Journal of Medical
by Elsevier Taiwan LLC. This is an open access article under the
d/4.0/).
Figure 1. (A) A deep and circumscribed ulcer in the left lower gingiva. (B) Histologically, the ulcer is surrounded by a sharp rim of
cellular infiltrate (hematoxylin and eosin stain, 40). (C) The polymorphous infiltrate includes Hodgkin/ReedeSternberg-like cells
with prominent nucleoli (hematoxylin and eosin stain, 1000). (DeG) Immunohistochemically, most atypical lymphocytes express
MUM-1 (E, 1000), CD30 (F, 1000), and LMP-1 (G, 1000) in a background of CD3-positive small T lymphocytes (D, 1000). (H and
I) Epstein-Barr virus was positive in variably sized lymphocytes forming a well-demarcated cellular rim around the ulcer (in situ
hybridization; H, 40 and I, 400).
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